134 related articles for article (PubMed ID: 9706062)
21. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
Sasaki M; Sudoh T; Fujimura A
Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
[TBL] [Abstract][Full Text] [Related]
22. Comparative bioavailability of two oral formulations of ranitidine.
Flores-Murrieta FJ; Toledo A; del Carmen Carrasco-Portugal M; Reyes-García G; Rodríguez-Silverio J; Medina-Santillán R; Herrera JE
Biopharm Drug Dispos; 2006 Jan; 27(1):23-7. PubMed ID: 16278926
[TBL] [Abstract][Full Text] [Related]
23. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine.
Williams MF; Dukes GE; Heizer W; Han YH; Hermann DJ; Lampkin T; Hak LJ
Pharm Res; 1992 Sep; 9(9):1190-4. PubMed ID: 1409403
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
Koch KM; Davis IM; Gooding AE; Yin Y
Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
Koch KM; Kerr BM; Gooding AE; Davis IM
Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
[TBL] [Abstract][Full Text] [Related]
26. Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humans.
Mojaverian P; Vlasses PH; Parker S; Warner C
Clin Pharmacol Ther; 1990 Mar; 47(3):382-8. PubMed ID: 2178854
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH
World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics of oral ranitidine in children and adolescents with cystic fibrosis.
James LP; Stowe CD; Farrar HC; Menendez AA; Argao EA
J Clin Pharmacol; 1999 Dec; 39(12):1242-7. PubMed ID: 10586389
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
Lacey LF; Frazer NM; Keene ON; Smith JT
Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
[TBL] [Abstract][Full Text] [Related]
30. Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.
Schulze JD; Waddington WA; Eli PJ; Parsons GE; Coffin MD; Basit AW
Pharm Res; 2003 Dec; 20(12):1984-8. PubMed ID: 14725363
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
32. Biliary excretion of H2-receptor antagonists.
Klotz U; Walker S
Eur J Clin Pharmacol; 1990; 39(1):91-2. PubMed ID: 1980465
[TBL] [Abstract][Full Text] [Related]
33. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
34. Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers.
Pérez-Guillé G; Guillé-Pérez A; Toledo-López A; Juárez-Olguín H; Flores Pérez C; Flores-Pŕez J; Carrasco-Portugal M; Lares-Asseff I; Camacho-Vieyra A
Proc West Pharmacol Soc; 2005; 48():84-8. PubMed ID: 16416668
[TBL] [Abstract][Full Text] [Related]
35. Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteers.
Tenero DM; Martin DE; Ilson BE; Boyle DA; Boike SC; Carr AM; Lundberg DE; Jorkasky DK
Ann Pharmacother; 1998 Mar; 32(3):304-8. PubMed ID: 9533060
[TBL] [Abstract][Full Text] [Related]
36. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
[TBL] [Abstract][Full Text] [Related]
37. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
Schmidt EK; Antonin KH; Flesch G; Racine-Poon A
Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
[TBL] [Abstract][Full Text] [Related]
38. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
Desager JP; Harvengt C
J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
[TBL] [Abstract][Full Text] [Related]
39. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
40. Validated HPLC method for the determination of ranitidine in human serum and its application in a clinical pharmacokinetic study.
Kumar MK; Jayasagar G; Chandrasekhar K; Ashok T; Rao YM
Pharmazie; 2003 Apr; 58(4):284-5. PubMed ID: 12749414
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
